Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
Lucas ArmangeFrançois BénézitLéa PicardCharlotte PronierStéphanie GuillotPierre-Axel LentzFrançois CarréPierre TattevinMatthieu RevestPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2021)
We performed a prospective cohort study of 311 outpatients with non-severe COVID-19 (187 women, median age 39 years). Of the 214 (68.8%) who completed the 6-week follow-up questionnaire, 115 (53.7%) had recovered. Others mostly reported dyspnea (n = 86, 40.2%), weight loss (n = 83, 38.8%), sleep disorders (n = 68, 31.8%), and anxiety (n = 56, 26.2%). Of those who developed ageusia and anosmia, these symptoms were still present at week 6 in, respectively, 11/111 (9.9%) and 19/114 (16.7%). Chest CT scan and lung function tests found no explanation in the most disabled patients (n = 23). This study confirms the high prevalence of persistent symptoms after non-severe COVID-19.
Keyphrases
- coronavirus disease
- sars cov
- lung function
- sleep quality
- weight loss
- end stage renal disease
- early onset
- computed tomography
- air pollution
- ejection fraction
- cystic fibrosis
- newly diagnosed
- chronic obstructive pulmonary disease
- chronic kidney disease
- respiratory syndrome coronavirus
- prognostic factors
- polycystic ovary syndrome
- physical activity
- bariatric surgery
- risk factors
- cross sectional
- contrast enhanced
- skeletal muscle
- adipose tissue
- depressive symptoms
- patient reported outcomes
- palliative care
- insulin resistance